- Home
- UBFO vs DERM Comparison
UBFO vs DERM Comparison
Compare UBFO & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBFO
- DERM
- Stock Information
- Founded
- UBFO 1987
- DERM 2014
- Country
- UBFO United States
- DERM United States
- Employees
- UBFO N/A
- DERM N/A
- Industry
- UBFO Major Banks
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- UBFO Finance
- DERM Health Care
- Exchange
- UBFO Nasdaq
- DERM Nasdaq
- Market Cap
- UBFO 162.0M
- DERM 181.0M
- IPO Year
- UBFO N/A
- DERM 2021
- Fundamental
- Price
- UBFO $8.64
- DERM $8.06
- Analyst Decision
- UBFO
- DERM Strong Buy
- Analyst Count
- UBFO 0
- DERM 2
- Target Price
- UBFO N/A
- DERM $10.00
- AVG Volume (30 Days)
- UBFO 23.4K
- DERM 103.3K
- Earning Date
- UBFO 07-17-2025
- DERM 05-14-2025
- Dividend Yield
- UBFO 5.56%
- DERM N/A
- EPS Growth
- UBFO N/A
- DERM N/A
- EPS
- UBFO 0.77
- DERM N/A
- Revenue
- UBFO $47,362,000.00
- DERM $56,243,000.00
- Revenue This Year
- UBFO N/A
- DERM $29.83
- Revenue Next Year
- UBFO N/A
- DERM $54.88
- P/E Ratio
- UBFO $11.17
- DERM N/A
- Revenue Growth
- UBFO N/A
- DERM N/A
- 52 Week Low
- UBFO $7.07
- DERM $3.54
- 52 Week High
- UBFO $10.49
- DERM $8.24
- Technical
- Relative Strength Index (RSI)
- UBFO 44.97
- DERM 65.90
- Support Level
- UBFO $8.44
- DERM $6.55
- Resistance Level
- UBFO $8.69
- DERM $7.00
- Average True Range (ATR)
- UBFO 0.28
- DERM 0.63
- MACD
- UBFO -0.06
- DERM 0.13
- Stochastic Oscillator
- UBFO 18.87
- DERM 92.41
About UBFO United Security Bancshares
United Security Bancshares operates as the holding for United Security Bank. It provides commercial banking services to the business and professional community, and individuals located in Fresno, Madera, Santa Clara, and Kern Counties. It offers checking and savings accounts, deposits, mortgage loans, credit and debit cards, safe deposit boxes, automated teller machines, wire transfers, money market accounts, mobile banking, and wealth management services. The company's primary sources of revenue are interest income from loans and investment securities.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.